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Abstract. The biological activity of ten prenylflavanones punfied 
from Sophora tomentosa L., and Sophora moorcroftiana Benth. 
ex Baker (Leguminosae) was investigated. The flavanones with 
prenyl-, Iavandulyl- or geranyl 8710ups on A ring, and two 
bioactive flavonostilbenes on ring B and stilbene (resveratrol) 
showed tumor-speclfic cytotoxic activity, antimicrobial activity, 
and anti-HIV activity, radical generation, and 02- scavenging 
activity. There was a positive relationship between radical gene-
ration and 02- scavenging activity in these prenylflavanones. 
These data sugg:est the medicinal sigmfican~e of prenylfla-
vanones. 
Some flavonoids such as flavones, isoflavones and calcones 
can modulate multidrug resistance (MDR) in cancer che-
motherapy by binding to transmembrane P-glycoprotein (P-
gp) which mediates anti-MDR action (1). By treatment with a 
flavonoid quercetin, the multidrug-resistant cells regained 
their sensitivity against adriamycin by inhibiting the ATP-
binding site of P-gp (2). The binding affinity of flavonoids 
depended on bot,h their class and substituents. Cytosolic P-gp 
flavonoid-binding site partly overlaps the ATP-binding site (3-
6). We investigated here the biological activity of prenyl-
flavanones, in conjunction with their radical modulating 
activity (determined by electron spin resonance (ESR) 
spectroscopy). 
Sophora species have been used worldwide as folklore 
medicines and their constituents have been identified. 
Sofalcone, a flavonoid derived from Sophora subprostrata had 
strong anti-ulcer activity (7, 8), and modified the gastric blood 
flow (9, 10). Sophoraflavanone G (5,7,2',4'-tetrahydroxy-8-
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lava dulylflavanone) also from a Sophora inhibited in vitro 
the growth of oral bacteria including primary cariogenic 
mut nt Streptococci, other oral Streptococci, Actinomycetes, 
and Lactobacilli (1 1).
In our studi s on pl nt root components, we found that 
antioxida ve act vities of isoflavones from Astragalus membra-
naceus Bunge were superior or similar to those of butyl 
hydroxyltoluenes (1~)･ The differences in antioxidant activi-
ies depended on the i teraction between their chemical 
structures and reactive oxygen species (13). This data suggest 
that a radical generation by these isoflavones might be related 
to these antioxidative effects. 
Materials and Methods 
Materials. The following chemicals and reagents were obtained from the 
indicated companies: RPM11640 medium, Dulbecco's modified Eagle 
medium (DMEM) (Gibco BRL, Grand Island, NY); fetal bovine serum 
(FBS) (JRH Biosci); 3-(4,5-d methylthiazol-2lyl)-2,5-diphenyltetra-
zolium bromide (MTT) (Wako ure Chem Ind., Ltd.,' Osaka); 3'-azido-
2',3'-dideoxythymidine (AZT), dideoxycytidine (ddC) (Sigma); dextran 
sulfate (8 kD) (Kowa, Tokyo); diethylenetriaminepentaacetic acid 
(DETAPAC) (Sigma Chem. Co., St. Louis, MO); 3,4-dihydr0-2,2-
dimethyl-2H-pyrrole-1-0xide (DMPO) (a spin trap agent) (Aldrich 
Chemical Comp. In, U.S.A.); superoxide dismutase (S0D) from bovine 
erythrocytes (Dojin, Kumamoto, Japan). A strain of Helicobacter pylori 
(ATCC43504) was purchased from American Type Culture Collection 
(Rockuille, MD). 
Compounds. Naringenin (5,7,4'-trihydroxyflavanQne) [YSOl] and hespe-
retin (5,7,3'- rihydroxy-4'-methoxyilavanone) [YS02] were purchased 
from Sigma Chemical Company. St. Louis, MO, U.S.A. 6-Prenylna-
ringenin [YS03], sophoraflavanone B [YS04] (14, 15), sophoraflavanone 
A [YS05] (14, 16), sophoraflavanone G rYS06] (17), sophoraflavanone D 
[YS07] (18), euchrestaflavanone A rYS08] (14, 19), sophoraflavanone H 
rYS09] (20) and soph rafl vanone I [YSIO] (20) were purified and 
characterized as described.
Assay for sytotoxic activty. Human squamous cell carcinoma (HSC-2) 
and human oral gingival fibroblasts (HGF) (5-7 population doubling 
levels) were cultured in DMEM medium supplemented with 10% heat-
inactivated FBS. These cells were incubated for 24 hr with the indicated 
concentrations of test samples. The relative viable cell number (absor-
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Figure I . structures ofprenylflavanones [YSO1-YSIOJ. 
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Table I. Diverse biological activity ofprenylflavanones fYSO1-YSIOJ. 
Compd Cytotoxic activityl) 
(CC50:ug/mL) (mM) 
Human oral tumor cell line 
Human 
gingival 
fibroblast 
(HGF) 
CC50 
( ug/mL) 
HSG 
Anti-HIV activity Radical 
EC50 SI generation 
(ug/mL) (CC50fEC50) (at pHI0.5) 
HSC-2 
02- scavenging 
activity at 
pH7.8 (SOD 
U/1.5 mg) 
YSO1 
YS02 
YS03 
YS04 
YS05 
YS06 
YS07 
YS08 
YS09 
YSIO 
425 (1.560) 
370 (1.230) 
22 (0.065) 
19 (0.056) 
< 16 (<0.039) 
<8 (<0.019) 
24 (0.055) 
17 (0.042) 
38 (0.065) 
15 (0.023) 
>500 ( > 1.840) 
480 (1.590) 
32 (0.094) 
20 (0.059) 
16 (0.039) 
8 (0.019) 
58 (0.132) 
31 (0.076) 
91 (0.156) 
50 (0.077) 
>5 0 (> 1.840) 
189 (0.630) 
35 (0.103) 
23 (0.068) 
13 (0.032) 
8 (0.019) 
45 (0.102) 
27 (0.066) 
100 (0.172) 
45 (0.069) 
> 200 
>200 
1 25 
95 
21 
23 
113 
69 
66 
114 
> 200 
> 200 
> 200 
> 200 
> 200 
?
> 200 
22 
23 
> 200 
><1 
><1 
<1 
<1 
<1 
?
<1 
?
?
<1 
<0.03 
<0.03 
0.25 
<0,03 
<0,03 
<0,03 
<0,03 
0,04 
1.14 
0.85 
1.5 
2.1 
17.1 
3.9 
4.8 
5.6 
48,0 
23.5 
1 60. 1 
72.6 
Dextran sulfate (ug/mL) 
AZT (uM) 
ddC (uM) 
> 1000 
277 
753 
0.44 
0.04 
0.26 
2273 
6925 
2896 
1) Near confluent HSC-2, HSG and HGF cells were incubated for 24 h with various concentrations of YSO1-YSIO and the relative viable cell number 
(A540) was determined by MTr method. Each value represents mean frorn duplicate determinations. Control A540 values of HSC-2, HSG and HGF 
cells were 0.97, 0.54 and 0.31, respectively. 
bance at 540 nm (A540)) was then determined by MTr assay. The 50% 
cyiotoxic concentration (CC50) was determined from the dose-response 
curve (21). 
Assay for anti-human immunodeficiency virus (HII~ activity. Human T 
cell leukemia virus I (HTLV1)-bearing CD4 positive human T cell lines, 
MT-4 cells, were infected with HIV-ImB at a multiplicity of5mfection 
(m.o,i.) of 0.01. HIV- or MOCK-infected MT-4 cells (1.5 x 10 /mL, 200 
uL) were placed into 96-well microtiter plates and incubated in the 
presence of varying concentrations of the fractions. After incubation for 
5 days at 37'C in a 5% C02 incubator, cell viability was quantified by a 
colorimetric assay (at 540 nm and 690 nm), monitoring the ability of 
viable cells to reduce MTT to a blue formazan product. All data 
represent the mean values of triplicate measurements. CC50 was 
determined with MOCK-infected cells, whereas EC50 was determined 
with HIV-infected cells. Selectivity index (SI) was defined as follows: 
SI=CC50/EC50 (22). 
Assay for radical intensty. Radical intensity was determined at 25 ' C 
using ESR spectroscopy (JEOL JES REIX, X-band, 100 kHZ 
modulation frequency). Instrument settings: center field, 335.6 :!: 5.0 
mT; microwave power, 8 mW; modulation amplitude, 0.1 mT; gain, 630 
time constant, 0.1 sec; scanning time, 2 min. Radical intensity was 
determined in 0.1M NaHC03/Na2C03 buffer (pH 10.5) containing 50% 
DMSO. The final concentration of compound was 1.5 mg/mL and the 
radical intensity was defined as the ratio of peak heights of these radicals 
to that of MnO (23). 
Superoxide anion (02-) scavenging activity. 02- was generated by 
h poxanthine (HX) and xanthi e oxidase (XOD) reaction (200 uL) [2 
mM HX (in 0.1 M PBS, pH 7.8) 50 uL, 0.5 mM DETAPAC 20 uL, 
DMPO 10 L, sample (in DMSO) 50 uL, H20 or SOD 30 uL, XOD (0.5 
U/mL in 0.1M PBS) 4 uL]. The gain was changed to 250. 02-
scavenging activity was xpressed as SOD unit/1.5 mg sample (24). 
Antimicrobial activity. T n compounds were investigated for antimi-
crobial act vity against fourteen bacteria. The test was carried out by 
serial dilutions of the compound in nutrient agar (Oxoid) base. 
Staphylococcus aureus 6571, 8530, 8531, Staphylococcus typhimurium 4, 
57, 59, Bacillus subtilis VB1, Shigella dysenteriae 1, Shigella sonnei 2, 
Escherichia coli Row, Escherichia coli R832, Klebsiella spp 14, Providencia 
spp 1, and Vibrio cholerae 865 from clinical isolates were obtained from 
Central Laboratory of Clinical Microbiology, University of Calcutta, 
India (25). 
Anti-Helicobacter pylori activty. A strain of Helicobacter pylori 
(ATCC43504) was purchased from American Type Culture Collection 
(Rockrille, MD). Muell r-Hilton broth containing 5% FBS was used as 
the medium, and was cultured in a jar conditioned with Campylo Pack 
(Dia latron) for 48 hours. Briefly, H. pylori strains were inoculated on a 
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Table II. Antimicrobial activity ofprenylflavanones fYSO11YSIOJ. 
Compd Gram-positive bacteria 
Staphylocbccus 
aureus 
Staphylococcus 
~phimurium 
Bacillus 
subtilis 
VB1 
Shigella 
6571 8530 8531 4 59 57 c5lsenteriae 1 
Gram-negative bacteria 
Esherichia Klebsiella 
coli spp 14 
sonnei 2 ROW R832 
Helicobacter 
P'Iovidencia V~brio pylori 
spp I cholerae 
865 MIC50 
(ugimL)1) 
YSOI >100 >100 >100 >100 >100 >100 >100 >100 
YS02 25 100 100 > 100 > 100 50 > 100 > 100 
YS03 25 50 50 > 100 > 100 > 100 >100 
YS04 50 25 25 > 100 > 100 > 100 >100 
YS05 25 25 25 > 100 > 100 > 100 >100 
50 
50 
25 
YS06 125 125 125 >100 >100 >100 >100 12.5 
YS07 25 12.5 >100 >100 >100 >100 >100 
YS08 12.5 12.5 >100 >100 >100 >100 >100 
YS09 25 12.5 >100 >100 >100 >100 >100 
25
25 
50
YSIO 12.5 25 >100 >100 >100 >100 >100 12.5 
>  > 1  10  100 
> 1 0 50 > 100 > 100
> 100 > 100 25 > 100 
> 100 > 100 12.5 > 100 
> 100 > 100 25 > 100 
> 100 > 100 2.5 > 100 
> 100 > 100 > 100 > 100 
> 1 0 > 100 > 100 > 100 
> 100 > 100 > 100 > 100 
> 1 0 > 1 0 > 1 0 > 100 
> 100 > 100 > 100.0 
50
>100 
>100 
> 100 
10  > 100.0 
25 > I O0.0 
25 68.0 
50 > 100.0 
> 100 12.5 5.8 
>100 100 21.0 
> 100 > 100 > 100.0 
> 100 > 100 2.6 
> 100 > 100 2. 1 
Clarithromycin 10.0 
1 ) The MIC value (ug/mL) was determined for each compound by a broth microdilution method using H. pylori (ATCC43504) (refs. 
YSOI and YS02: each equivqlent mixture of 2R and 2S. 
26 and 27). Each 
Brucella agar plate containing 10% horse serum, and cultured at 37'C7 
for 48 hours. The bacterial colonies collected were diluted to 10 
colony forming unit (CFU)/mL with 0.9% saline. The extracts were 
dissolved in DMSO, and then diluted with Mueller-Hilton broth. To 
the solution 06f the extracts, each bacterial suspension was added to a 
density of 10 colony forming units (CFU)/100 mL/well. The mixture 
was incubated at 37'C for 48 hours. The minimum inhibitory 
concentration (MIC) of each fraction was calculated from the dose-
response curve (26, 27). 
Results 
Cytotoxic activity. Among ten prenylflavanones, four 
compounds [YS04, YS05, YS06, YS08] showed higher 
cytotoxic activity against both two oral tumor cell lines 
(HSC-2, HSG) (Table I). HSG cells were more resistant 
than HSC-2 cells. In particular, YS09 and YSIO showed 
higher cytotoxic activity against tumor cells (HSC-2, HSG) 
than against normal human gingival fibroblast (HGF) 
(Table I). 
Radical generation and 02- scavenging activity. Among ten 
prenylflavanones, flavonostilbenes of ~rS09, YSIO] produced 
stronger ESR signal of radical at pHI0.5 than other seven 
compounds, followed by YS03. The other compounds did not 
produce any d tectable amount of radical. YS09 (160.1 SOD 
unit/1.5 g) showed the highest 02- scavenging activity, 
followed by YSIO (72.6 SOD unit), YS07 (48.0 SOD unit), 
YS08 (23.5 SOD unit), YS03 (17.1 SOD unit) and YS06 (5.6 
SOD unit) (Figure 2) (Table I). 
Antimicrobial activity. YS06 (10 u~mL) showed the highest 
antibacterial activity against three strains of Staphylococcus 
aureus 6571, 8530 and 8531, followed by YS08, YS09 and 
YSIO (Table II). YS06 was also_ effective against Shigella 
dysenteriae 1, E. coli R832 and Vibrio cholerae 865. 
YSIO showed the highest anti=H. pylori activity, followed by 
YS09 and YS06 (Table II). 
Discussion 
Anti-human immunodeficiency virus (HIV) activity. A com-
pound YS06 showed the highest anti-HIV activity (Selectivity 
Index (SI=5), followed by YS08 (SI=3) and YS09 (SI=3) 
(Table I). The other seven compounds were inactive (SI= 1). 
We found that two prenylflavanones ~(S09, YSIO] of a 
flavonostilbe e type with the skeletons of flavanone on B ring 
a  stilbe e (resveratrol) showed remarkable properties, 
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Figure 3. Relationship between radical generation (at pH 10.5) and 02-
scavenging (SOD) activity (atpH 7.8). 
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Figure 2. ESR spectra of prenylflavanones fYSO1-YSIOJ. Samples were 
applied to ESR spectroscopy I min after being dissolved in O. I M 
NaHC031Na2C03 buffer (pHI0.5) containing 50% DMSO. 
possibly due to their cell membrane affinity (28) (Table I). 
These compounds showed selective cytotoxicity against turnor 
cells than against normal cells, produced higher amounts of 
radical (Figure 2), and showed the highest 02- scavenging 
activity. 
When the 02- scavenging activity of ten prenylflavanones 
was plotted vs. SOD activity, there was a positive correlation 
between these parameters (an equation in Figure 3). 
Introduction of lavandulyl group at A ring [YS06, YSIO] 
enhanced significantly these activities, whereas substitution by 
hydrogen at R1 and R2 on A ring ,rSO1, YS02] considerably 
reduced the biological activity. We have recently found that 
polyprenylalcohols such as geranylgeraniol and geranyl-
farnesol neither produced any radical nor scavenged 02-･ This 
data suggest that many compounds display both radical 
generation and 02- scavenging activity. 
We found that three compounds ~(S06, YS08, YS09] 
showed the highest anti-HIV activity (SI=3-5.0) among ten 
compounds. These compounds have either lavandulyl- or 
prenyl group at position R1 of A ring. This suggests that both 
hydrophobic groups (1avandulyl- or prenyl group) on A ring 
and hydrophilic group (hydroxyl group) on B ring in the same 
structure might markedly enhance their binding affinity with 
cell membrane. Especially, two lavandulyl- and hydroxyl 
groups such as YS06 (SI=5) might be important determinants 
of the anti-HIV activity. 
We found that YS06 (10 mgimL) showed the highest anti-
bacterial activity among ten compounds against three 
Staphylococcus aureus, Shigella dysenteriae 1, E. coli R832, and 
Vibrio cholerae 865, followed by two flavonostilbenes nrS09, 
YSIO] (Table II). Previous reports have demonstrated the 
efficacy of YS06 against other bacterial strains (11). On the 
other hand, flavonostilbenes [YS09, YSIO] were more 
effective against H. pylori, as compared with YS06. 
The pr sent study demonstrated several interesting 
properties of two flavonostilbenes (sophoraflavanone H 
rYS09], sophoraflavanone I rYSIO]): tumor specific-cytotoxic 
activity, antimicrobial activity, anti-HIV activity, ' radical 
g neration and 02- scavenging activity. There remains to 
investigate the mechanism by which YS09 and YSIO induce 
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these effects. We have recently found that isoprenoid-
substituted flavonoids induced apoptotic cell death (29), more 
potently than tannin-related compounds (30). Further 
screening of flavonoids, especially those which have 
isoprenoid side chains, is under way. 
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